Tomentosin mitigates the LPS induced cardiac injury by regulating Nrf-2/Nf-κβ pathway in mice

  • Eur J Pharmacol. 2025 Jun 5:996:177589. doi: 10.1016/j.ejphar.2025.177589.
Mehmet Güvenç  1 Tuba Aydin  2 Tuncer Kutlu  3 Muhammed Etyemez  4 Cafer Tayer İşler  5
Affiliations
  • 1. Department of Physiology, Faculty of Veterinary Medicine, University of Hatay Mustafa Kemal, Hatay, 31060, Turkey. Electronic address: [email protected].
  • 2. Department of Pharmacognosy, Faculty of Pharmacy, Ağrı İbrahim Çeçen University, Ağrı, 04100, Turkey.
  • 3. Department of Pathology, Faculty of Veterinary Medicine, University of Hatay Mustafa Kemal, Hatay, 31060, Turkey.
  • 4. Department of Physiology, Faculty of Veterinary Medicine, University of Kastamonu, Kastamonu, 37150, Turkey.
  • 5. Department of Surgery, Faculty of Veterinary Medicine, University of Hatay Mustafa Kemal, Hatay, 31060, Turkey.
Abstract

Endotoxemic shock is a severe complication characterized by multiple organ failure, hypotension, and impaired tissue perfusion, all contributing to high morbidity and mortality. Recent studies have highlighted the anti-inflammatory and antioxidant properties of tomentosin. This study investigates the protective effects of tomentosin against lipopolysaccharide (LPS)-induced cardiac injury and elucidates its underlying mechanisms. Mice were pre-treated with tomentosin before the LPS administration. Subsequently, cardiac injury markers, oxidative stress parameters, inflammatory mediators, and Nrf-2/NF-κB protein expression levels were analysed. The results demonstrated that tomentosin significantly reduced Troponin and CK-MB levels, alleviated oxidative stress, and suppressed inflammatory responses. Furthermore, tomentosin inhibited NF-κB activation while enhancing Nrf-2 expression. In conclusion, our findings suggest that tomentosin exerts cardioprotective effects by modulating the Nrf-2/NF-κB pathway, positioning it as a potential therapeutic candidate for preventing LPS-induced cardiac dysfunction.

Keywords
Cardiac injury; Inflammation; Lipopolysaccharide; Nrf-2/NF-κB; Sepsis; Tomentosin.
Products